Physiomics wins new contract with Numab Therapeutics
14th Apr 2026 15:35
(Sharecast News) - AIM-listed biotech Physiomics has announced a new contract with client Numab Therapeutics to help development activities for the latter's oncology pipeline.
Read morePhysiomics secures follow-on contract with existing client
15th Dec 2025 09:47
(Sharecast News) - Data science and biostatistics company Physiomics has secured a follow on contract worth up to £169,000 with an existing UK-based client.
Read morePhysiomics scores new contract with long standing client
16th Jul 2025 07:54
(Sharecast News) - Mathematical modelling and biostatistics firm Physiomics said on Wednesday that it had secured a new contract with long-standing client, Numab Therapeutics.
Read morePhysiomics total income grows in FY25, pre-tax losses improve
14th Jul 2025 08:46
(Sharecast News) - Data science and biostatistics firm Physiomics said on Monday that both total income and pre-tax losses would exceed market expectations for the financial year ended 30 June.
Read morePhysiomics secures two new contracts, names head of biometrics unit
16th Jun 2025 09:04
(Sharecast News) - Data science and biostatistics company Physiomics said on Monday that it had secured two new contracts with a UK-headquartered clinical-stage biopharmaceutical company.
Read morePhysiomics scores 'sizeable contract extension'
29th May 2025 09:47
(Sharecast News) - Data science and biostatistics company Physiomics said on Thursday that it has secured a "sizeable contract extension award" with an existing large pharmaceutical client.
Read morePhysiomics secures new contract with UK client
9th May 2025 09:10
(Sharecast News) - Data science and biostatistics company Physiomics revealed on Friday that it has secured a contract award with a new UK client.
Read morePhysiomics project gets regulatory and ethical approval
8th Jan 2025 14:12
(Sharecast News) - Mathematical modelling, data science and biostatistics specialist Physiomics announced on Wednesday that its Innovate UK-funded 'PREDICT-ONC' project had received both regulatory and ethical approval.
Read morePhysiomics announces new modelling and data sciences manager
4th Nov 2024 12:11
(Sharecast News) - Physiomics announced the appointment of Mark Davies as its head of quantitative pharmacology and data science on Monday.
Read morePhysiomics secures new contract from existing pharma client
17th Sep 2024 13:38
(Sharecast News) - Physiomics, a specialist in mathematical modelling and data science for drug development and personalised medicine, announced on Tuesday that it has secured a new contract worth £65,000 from an existing large pharmaceutical client.
Read morePhysiomics secures new contract from existing pharma client
17th Sep 2024 13:38
(Sharecast News) - Physiomics, a specialist in mathematical modelling and data science for drug development and personalised medicine, announced on Tuesday that it has secured a new contract worth £65,000 from an existing large pharmaceutical client.
Read morePhysiomics re-engages with DoseMe for personalised dosing software
14th Jun 2024 09:51
(Sharecast News) - Physiomics, a mathematical modelling and data science specialist focussed on therapeutics and personalised medicine, has re-engaged with DoseMe to implement its personalised dosing software on the 'DoseMeRx' platform, it announced on Friday.
Read morePhysiomics wins new contract with existing client
13th Jun 2024 09:56
(Sharecast News) - Data sciences business Physiomics said on Thursday that it has been awarded a new contract by an existing, large client.
Read morePhysiomics lowers forecasts amid contract delays
3rd May 2024 11:21
(Sharecast News) - Therapeutics and medicine-focussed mathematical modelling and data science company Physiomics said in an update on Friday that, despite a robust pipeline of potential new business, it had experienced delays in signing several large contracts.
Read morePhysiomics secures 'substantial new contract' with existing pharma client
18th Mar 2024 09:43
(Sharecast News) - Mathematical modelling and data science company Physiomics has been awarded "a substantial new contract" by an existing large pharmaceutical client.
Read more